4′-Iodo-4′-Deoxydoxorubicin Disrupts the Fibrillar Structure of Transthyretin Amyloid
- 1 June 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (6) , 1919-1925
- https://doi.org/10.1016/s0002-9440(10)65065-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantationEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- ‘In vitro’ amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variantsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Anti-Amyloid DrugsDrugs & Aging, 1996
- Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG)Nucleic Acids Research, 1995
- Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP)Biochemistry, 1991
- Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine TAnalytical Biochemistry, 1989
- Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbuminBiochemical and Biophysical Research Communications, 1988
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980
- The characterization of soluble amyloid prepared in waterJournal of Clinical Investigation, 1968